380 related articles for article (PubMed ID: 17530220)
21. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings.
Garnacho-Montero J; Ortiz-Leyba C; Fernández-Hinojosa E; Aldabó-Pallás T; Cayuela A; Marquez-Vácaro JA; Garcia-Curiel A; Jiménez-Jiménez FJ
Intensive Care Med; 2005 May; 31(5):649-55. PubMed ID: 15785929
[TBL] [Abstract][Full Text] [Related]
22. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.
Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A
Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994
[TBL] [Abstract][Full Text] [Related]
23. Ventilator-associated pneumonia with Col-S strains: a successful comeback of colistin!
Mukhopadhyay C; Krishna S; Vandana KE; Shenoy A; Bairy I
Braz J Infect Dis; 2008 Oct; 12(5):444-6. PubMed ID: 19219287
[TBL] [Abstract][Full Text] [Related]
24. Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review.
Celik IH; Oguz SS; Demirel G; Erdeve O; Dilmen U
Eur J Pediatr; 2012 Feb; 171(2):311-6. PubMed ID: 21809011
[TBL] [Abstract][Full Text] [Related]
25. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
[TBL] [Abstract][Full Text] [Related]
26. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU.
Kallel H; Bahloul M; Hergafi L; Akrout M; Ketata W; Chelly H; Hamida CB; Rekik N; Hammami A; Bouaziz M
Int J Antimicrob Agents; 2006 Oct; 28(4):366-9. PubMed ID: 16971093
[TBL] [Abstract][Full Text] [Related]
27. Impact of colistin-initiation delay on mortality of ventilator-associated pneumonia caused by A. baumannii.
Samrah S; Bashtawi Y; Hayajneh W; Almomani B; Momany S; Khader Y
J Infect Dev Ctries; 2016 Oct; 10(10):1129-1134. PubMed ID: 27801377
[TBL] [Abstract][Full Text] [Related]
28. Acinetobacter baumannii ventilator-associated pneumonia: epidemiology, clinical characteristics, and prognosis factors.
Chaari A; Mnif B; Bahloul M; Mahjoubi F; Chtara K; Turki O; Gharbi N; Chelly H; Hammami A; Bouaziz M
Int J Infect Dis; 2013 Dec; 17(12):e1225-8. PubMed ID: 24094525
[TBL] [Abstract][Full Text] [Related]
29. Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance.
Ghannam DE; Rodriguez GH; Raad II; Safdar A
Eur J Clin Microbiol Infect Dis; 2009 Mar; 28(3):253-9. PubMed ID: 18752007
[TBL] [Abstract][Full Text] [Related]
30. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
Khawcharoenporn T; Pruetpongpun N; Tiamsak P; Rutchanawech S; Mundy LM; Apisarnthanarak A
Int J Antimicrob Agents; 2014 Apr; 43(4):378-82. PubMed ID: 24613422
[TBL] [Abstract][Full Text] [Related]
31. Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.
Inchai J; Liwsrisakun C; Theerakittikul T; Chaiwarith R; Khositsakulchai W; Pothirat C
J Infect Chemother; 2015 Aug; 21(8):570-4. PubMed ID: 26026660
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
[TBL] [Abstract][Full Text] [Related]
33. Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report.
Nakwan N; Wannaro J; Thongmak T; Pornladnum P; Saksawad R; Nakwan N; Chokephaibulkit K
Pediatr Pulmonol; 2011 Jan; 46(1):60-6. PubMed ID: 20812247
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
[TBL] [Abstract][Full Text] [Related]
35. Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases.
Özvatan T; Akalın H; Sınırtaş M; Ocakoğlu G; Yılmaz E; Heper Y; Kelebek N; İşçimen R; Kahveci F
Respirology; 2016 Feb; 21(2):363-9. PubMed ID: 26635315
[TBL] [Abstract][Full Text] [Related]
36. Triple combination therapy with high-dose ampicillin/sulbactam, high-dose tigecycline and colistin in the treatment of ventilator-associated pneumonia caused by pan-drug resistant Acinetobacter baumannii: a case series study.
Assimakopoulos SF; Karamouzos V; Lefkaditi A; Sklavou C; Kolonitsiou F; Christofidou M; Fligou F; Gogos C; Marangos M
Infez Med; 2019 Mar; 27(1):11-16. PubMed ID: 30882373
[TBL] [Abstract][Full Text] [Related]
37. Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia.
Oliva A; Cipolla A; Vullo V; Venditti M; Mastroianni CM; Falcone M
New Microbiol; 2017 Jul; 40(3):205-207. PubMed ID: 28675246
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Borraz C; Gudiol F
J Antimicrob Chemother; 2004 Dec; 54(6):1085-91. PubMed ID: 15546972
[TBL] [Abstract][Full Text] [Related]
39. Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia.
Yilmaz GR; Guven T; Guner R; Kocak Tufan Z; Izdes S; Tasyaran MA; Acikgoz ZC
J Infect Dev Ctries; 2015 May; 9(5):476-85. PubMed ID: 25989167
[TBL] [Abstract][Full Text] [Related]
40. Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.
Vardakas KZ; Voulgaris GL; Samonis G; Falagas ME
Int J Antimicrob Agents; 2018 Jan; 51(1):1-9. PubMed ID: 28669836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
